A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples

SARS-CoV-2, a novel human coronavirus, has created a global disease burden infecting > 100 million humans in just over a year. RT-PCR is currently the predominant method of diagnosing this viral infection although a variety of tests to detect viral antigens have also been developed. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangalaparthi, Kiran K., Chavan, Sandip, Madugundu, Anil K., Renuse, Santosh, Vanderboom, Patrick M., Maus, Anthony D., Kemp, Jennifer, Kipp, Benjamin R., Grebe, Stefan K., Singh, Ravinder J., Pandey, Akhilesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532087/
https://www.ncbi.nlm.nih.gov/pubmed/34686148
http://dx.doi.org/10.1186/s12014-021-09331-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532087/
https://www.ncbi.nlm.nih.gov/pubmed/34686148
http://dx.doi.org/10.1186/s12014-021-09331-z

Ejemplares similares